AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34606049 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified Vocational Advice Intervention (SVAI) delivered by physiotherapists, all sessions conducted by telephone, number of sessions not specified.
Number of subjects: 170
Study 34606049 — intervention group
Group type: EXPERIMENTAL
Intervention: Stratified Vocational Advice Intervention (SVAI)
Number of subjects: 170
Study 32114088 — intervention group
Group type: EXPERIMENTAL
Intervention: Third person objective narrative voice
Number of subjects: 258
Study 32114088 — intervention group
Group type: COMPARATOR
Intervention: Personal narrative voice
Number of subjects: 258
Study 32114088 — intervention group
Group type: COMPARATOR
Intervention: Mixed narrative voice
Number of subjects: 258
Study 32114088 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep blog posts
Number of subjects: 258
Study 32114088 — intervention group
Group type: COMPARATOR
Intervention: Vaccine blog posts
Number of subjects: 258
Study 32114088 — intervention group
Group type: EXPERIMENTAL
Intervention: All narrative voices
Number of subjects: 258
Study 35978182 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled CVC removal after 14 days
Number of subjects: 2984
Study 35978182 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled CVC removal after 7 days
Number of subjects: 2984
Study 35978182 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled CVC removal after 21 days
Number of subjects: 2984
Study 35978182 — intervention group
Group type: COMPARATOR
Intervention: Unscheduled CVC removal (control group)
Number of subjects: 2984
Study 34018624 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomization-based inference for a marginal treatment effect in SWTs
Number of subjects: 0
Study 34018624 — intervention group
Group type: EXPERIMENTAL
Intervention: Test statistics derived from individual-level generalized linear models
Number of subjects: 0
Study 34018624 — intervention group
Group type: EXPERIMENTAL
Intervention: Data from the XpertMTB/RIF tuberculosis trial
Number of subjects: 0
Study 35872928 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupotomy and electroacupuncture therapy
Number of subjects: 60
Study 35872928 — intervention group
Group type: COMPARATOR
Intervention: Hot compress, oral medication, and local injection
Number of subjects: 60
Study 33645201 — intervention group
Group type: COMPARATOR
Intervention: Parathyroid hormone 1‐34 alone (Group A)
Number of subjects: 96
Study 33645201 — intervention group
Group type: EXPERIMENTAL
Intervention: Parathyroid hormone 1‐34 plus Zoledronic Acid (ZA) (Group B)
Number of subjects: 96
Study 32554770 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 959
Study 32554770 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslipidemia
Number of subjects: 959
Study 32554770 — intervention group
Group type: EXPERIMENTAL
Intervention: Migraine
Number of subjects: 959
Study 35749557 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-abortion phone follow-up by a nurse (trained in person-centered abortion care)
Number of subjects: 371
Study 35749557 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (follow-up by service provider call center)
Number of subjects: 371
Study 35749557 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-abortion phone follow-up by a peer counselor (trained in person-centered abortion care)
Number of subjects: 371
Study 33482681 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic doses of novel direct oral anticoagulants (DOACs)
Number of subjects: 0
Study 33482681 — intervention group
Group type: COMPARATOR
Intervention: Low-molecular-weight heparins (LMWHs)
Number of subjects: 0
Study 32843308 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualized nomogram model based on predictors (maternal age, MsAMH concentration, number of oocytes retrieved)
Number of subjects: 4783
Study 32843308 — intervention group
Group type: EXPERIMENTAL
Intervention: Visualized nomogram model validated on independent data from testing set
Number of subjects: 4783
Study 35340062 — intervention group
Group type: EXPERIMENTAL
Intervention: Denosumab every six months
Number of subjects: 110
Study 35340062 — intervention group
Group type: COMPARATOR
Intervention: Denosumab and Risedronate
Number of subjects: 110
Study 33305618 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 131
Study 33305618 — intervention group
Group type: COMPARATOR
Intervention: Active control program (relaxation)
Number of subjects: 131
Study 34533487 — intervention group
Group type: EXPERIMENTAL
Intervention: RE only
Number of subjects: 16
Study 34533487 — intervention group
Group type: EXPERIMENTAL
Intervention: SS
Number of subjects: 16
Study 34533487 — intervention group
Group type: EXPERIMENTAL
Intervention: MM
Number of subjects: 16
Study 34533487 — intervention group
Group type: EXPERIMENTAL
Intervention: RE + SS
Number of subjects: 16
Study 34533487 — intervention group
Group type: COMPARATOR
Intervention: Rest control (CON)
Number of subjects: 16
Study 33541274 — intervention group
Group type: EXPERIMENTAL
Intervention: Colistin-based combination therapy
Number of subjects: 33
Study 33541274 — intervention group
Group type: EXPERIMENTAL
Intervention: CPE isolates carrying blaOXA‐232 or blaNDM‐1
Number of subjects: 33
Study 33541274 — intervention group
Group type: EXPERIMENTAL
Intervention: CPE isolates
Number of subjects: 33
Study 33541274 — intervention group
Group type: EXPERIMENTAL
Intervention: CPKP-ST231
Number of subjects: 33
Study 33541274 — intervention group
Group type: EXPERIMENTAL
Intervention: Siderophores yersiniabactin and aerobactin
Number of subjects: 33
Study 32077514 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture on specific points
Number of subjects: 49
Study 32077514 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture on non-specific points
Number of subjects: 49
Study 35680197 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with at least 1 SMuRF
Number of subjects: 2862
Study 35680197 — intervention group
Group type: COMPARATOR
Intervention: SMuRF-less patients
Number of subjects: 2862
Study 32406064 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 respirators
Number of subjects: 20
Study 32406064 — intervention group
Group type: COMPARATOR
Intervention: Medical masks
Number of subjects: 20
Study 32406064 — intervention group
Group type: EXPERIMENTAL
Intervention: N95 respirators and medical masks
Number of subjects: 20
Study 35931948 — intervention group
Group type: EXPERIMENTAL
Intervention: Median nerve block (5 ml of 0.5% lidocaine)
Number of subjects: 92
Study 35931948 — intervention group
Group type: EXPERIMENTAL
Intervention: Median nerve block
Number of subjects: 92
Study 35931948 — intervention group
Group type: COMPARATOR
Intervention: Control group (subcutaneous local block)
Number of subjects: 92
Study 35931948 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 92
Study 36147260 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-Optimized (WFO) PRK
Number of subjects: 181
Study 36147260 — intervention group
Group type: EXPERIMENTAL
Intervention: Wavefront-Guided (WFG) PRK
Number of subjects: 181
Study 34478235 — intervention group
Group type: EXPERIMENTAL
Intervention: Native vessel PCI
Number of subjects: 3983
Study 34478235 — intervention group
Group type: EXPERIMENTAL
Intervention: Venous graft PCI
Number of subjects: 3983
Study 34478235 — intervention group
Group type: EXPERIMENTAL
Intervention: Arterial graft PCI
Number of subjects: 3983
Study 34478235 — intervention group
Group type: COMPARATOR
Intervention: Overall PCI (native, venous, arterial)
Number of subjects: 3983
Study 32830092 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton Pump Inhibitors (PPIs)
Number of subjects: 186
Study 34491291 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP)
Number of subjects: 10
Study 32866837 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% imidacloprid + 2.5% moxidectin (topical once monthly for 9 months) and doxycycline (10 mg/kg twice daily for 28 days)
Number of subjects: 37
Study 32866837 — intervention group
Group type: COMPARATOR
Intervention: Melarsomine dihydrochloride (2.5 mg/kg, two injections 24 hours apart)
Number of subjects: 37
Study 35101883 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy
Number of subjects: 98
Study 35101883 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus chemotherapy
Number of subjects: 98
Study 35101883 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab plus chemotherapy (in subgroup with PD-L1 expression ≥50%)
Number of subjects: 98
Study 35101883 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus chemotherapy (in subgroup with PD-L1 expression ≥50%)
Number of subjects: 98
Study 33826418 — intervention group
Group type: EXPERIMENTAL
Intervention: BreastFeeding Friend (BFF) app
Number of subjects: 100
Study 33826418 — intervention group
Group type: COMPARATOR
Intervention: Control app
Number of subjects: 100
Study 33826418 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study 33826418 — intervention group
Group type: EXPERIMENTAL
Intervention: Low quartile users
Number of subjects: 100
Study 32491239 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI-based radiomics signature
Number of subjects: 293
Study 32491239 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined nomogram integrating independent clinical risk factor α‐fetoprotein (AFP) and radiomics signature
Number of subjects: 293
Study 35476747 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction (MBSR)
Number of subjects: 103
Study 35476747 — intervention group
Group type: COMPARATOR
Intervention: Health education classes
Number of subjects: 103
Study 33453563 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 230
Study 33453563 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 230
Study 32819923 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS)
Number of subjects: 146
Study 32819923 — intervention group
Group type: COMPARATOR
Intervention: Sham TEAS (STEAS)
Number of subjects: 146
Study 36331540 — intervention group
Group type: EXPERIMENTAL
Intervention: Renew mobile mental health app with support from a research staff member
Number of subjects: 93
Study 36331540 — intervention group
Group type: EXPERIMENTAL
Intervention: Renew mobile mental health app without support from a research staff member
Number of subjects: 93
Study 36331540 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (delayed use condition)
Number of subjects: 93
Study 33148722 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise and dietary intervention
Number of subjects: 122
Study 33148722 — intervention group
Group type: COMPARATOR
Intervention: Usual care control group
Number of subjects: 122
Study 35322711 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose vitamin D supplementation (50,000 IU on the first day followed by 10,000 IU/day for 29 days)
Number of subjects: 0
Study 35322711 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving 1000 IU vitamin D daily and a placebo soft gel
Number of subjects: 0
Study 32602347 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning algorithms based on the mobile screening test system for mild cognitive impairment (mSTS‐MCI)
Number of subjects: 177
Study 32602347 — intervention group
Group type: COMPARATOR
Intervention: Korean version of MoCA
Number of subjects: 177
Study 32242254 — intervention group
Group type: EXPERIMENTAL
Intervention: Regulated dual-task (RDT)
Number of subjects: 12
Study 32242254 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study 32242254 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulated dual-task (SDT)
Number of subjects: 12
Study 33485328 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid-free perioperative analgesic pathway
Number of subjects: 0
Study 33485328 — intervention group
Group type: COMPARATOR
Intervention: Traditional opioid-including perioperative medications
Number of subjects: 0
Study 32620298 — intervention group
Group type: EXPERIMENTAL
Intervention: Gambling involvement measured by six types of gambling behaviours and gambling-related problems in the last year.
Number of subjects: 511
Study 32620298 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk factors identified: male gender, wave 1 gambling, sensation seeking, delinquency, and cyberbullying.
Number of subjects: 511
Study 32620298 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective factors identified: positive relationships with parents and meaningful activities.
Number of subjects: 511
Study 36915205 — intervention group
Group type: COMPARATOR
Intervention: ENG‐IMPLANT
Number of subjects: 66
Study 36915205 — intervention group
Group type: EXPERIMENTAL
Intervention: DSG + ENG‐IMPLANT
Number of subjects: 66
Study 33476534 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine citrate injection (5 mg/kg) at 1 hour before ventilator weaning
Number of subjects: 338
Study 33476534 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment with caffeine
Number of subjects: 338
Study 32490650 — intervention group
Group type: EXPERIMENTAL
Intervention: VAH+CAP+SSLF (Group 2)
Number of subjects: 150
Study 32490650 — intervention group
Group type: COMPARATOR
Intervention: VAH+CAP (Group 1)
Number of subjects: 150
Study 35033540 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsulotomy first (Caps-First)
Number of subjects: 70
Study 35033540 — intervention group
Group type: COMPARATOR
Intervention: Fragmentation first (Frag-First)
Number of subjects: 70
Study 34434228 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF) training
Number of subjects: 44
Study 34434228 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation (R)
Number of subjects: 44
Study 35178149 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (trained using the adapted Pathfinder International Teaching Package on misoprostol use)
Number of subjects: 68
Study 35178149 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (after training)
Number of subjects: 68
Study 32040883 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar directional stimulation (DIRECT)
Number of subjects: 14
Study 32040883 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar stimulation (BIPOLAR = circular anode)
Number of subjects: 14
Study 32040883 — intervention group
Group type: EXPERIMENTAL
Intervention: Directional bipolar stimulation (BI‐DIRECT = directional anode)
Number of subjects: 14
Study 32040883 — intervention group
Group type: COMPARATOR
Intervention: Bipolar stimulation (BI‐DIRECT)
Number of subjects: 14
Study 32040883 — intervention group
Group type: COMPARATOR
Intervention: All stimulation conditions
Number of subjects: 14
Study 36168097 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 92
Study 36168097 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music)
Number of subjects: 92
Study 33237533 — intervention group
Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg once daily
Number of subjects: 0
Study 33237533 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32314327 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transplantation (Ltx)
Number of subjects: 0
Study 32314327 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment of non-resectable, non-ablatable CLM
Number of subjects: 0
Study 35430794 — intervention group
Group type: EXPERIMENTAL
Intervention: Carb/fat balance dietary pattern
Number of subjects: 242
Study 35430794 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesogenic dietary pattern
Number of subjects: 242
Study 35430794 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss
Number of subjects: 242
Study 35430794 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary changes (energy intake, fat and carbohydrate intakes)
Number of subjects: 242
Study 33477909 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable wipes (DWs)
Number of subjects: 138
Study 33477909 — intervention group
Group type: COMPARATOR
Intervention: Soap and water (SAW)
Number of subjects: 138
Study 33477909 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing staff satisfaction with DWs
Number of subjects: 138
Study 35292088 — intervention group
Group type: EXPERIMENTAL
Intervention: Electro-acupuncture treatment
Number of subjects: 300
Study 35292088 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (control)
Number of subjects: 300
Study 34391963 — intervention group
Group type: EXPERIMENTAL
Intervention: 18L:6D
Number of subjects: 300
Study 34391963 — intervention group
Group type: EXPERIMENTAL
Intervention: 16L:8D and 18L:6D
Number of subjects: 300
Study 34391963 — intervention group
Group type: EXPERIMENTAL
Intervention: ?18 h photoperiods
Number of subjects: 300
Study 32146720 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP combined with laser therapy
Number of subjects: 24
Study 32146720 — intervention group
Group type: COMPARATOR
Intervention: SRP only (control)
Number of subjects: 24
Study 32146720 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (SRP with and without laser therapy)
Number of subjects: 24
Study 35351726 — intervention group
Group type: EXPERIMENTAL
Intervention: Let's Grow mHealth intervention
Number of subjects: 1100
Study 35351726 — intervention group
Group type: COMPARATOR
Intervention: Usual care plus electronic newsletters
Number of subjects: 1100
Study 33973840 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital Breast Tomosynthesis (DBT)
Number of subjects: 28749
Study 33973840 — intervention group
Group type: COMPARATOR
Intervention: Digital Mammography (DM)
Number of subjects: 28749
Study 32584384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injections (2 mg) monthly for 12 months
Number of subjects: 32
Study 32584384 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal aflibercept injections (2 mg) quarterly for 12 months
Number of subjects: 32
Study 32584384 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injections (2 mg) monthly or quarterly for 12 months
Number of subjects: 32
Study 34290385 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback device for ventilation
Number of subjects: 40
Study 34290385 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback device for chest compression
Number of subjects: 40
Study 34290385 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback device during chest compression
Number of subjects: 40
Study 34290385 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback device during ventilation
Number of subjects: 40
Study 34290385 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback device
Number of subjects: 40
Study 33563325 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin plus standard of care (500 mg qd for 5 days)
Number of subjects: 284
Study 33563325 — intervention group
Group type: COMPARATOR
Intervention: Standard of care alone
Number of subjects: 284
Study 33725432 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 vaccine (AZD1222), 5×10^10 viral particles, two doses 21 to 35 days apart
Number of subjects: 2026
Study 33725432 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride solution)
Number of subjects: 2026
Study 33725432 — intervention group
Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV-19 vaccine (AZD1222)
Number of subjects: 2026
Study 32048278 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard flow rate facemask
Number of subjects: 80
Study 32048278 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen with simple facemask
Number of subjects: 80
Study 32048278 — intervention group
Group type: EXPERIMENTAL
Intervention: High-flow nasal oxygen
Number of subjects: 80
Study 32048278 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen (control)
Number of subjects: 80
Study 35221319 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Ligilactobacillus salivarius subsp infantis PS11603 and Bifidobacterium longum PS10402)
Number of subjects: 30
Study 35221319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32023608 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (n = 101)
Number of subjects: 478
Study 32023608 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 86)
Number of subjects: 478
Study 32023608 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (females)
Number of subjects: 478
Study 32023608 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram (males)
Number of subjects: 478
Study 34492623 — intervention group
Group type: COMPARATOR
Intervention: Generational status (traditionalists, baby boomers, generation X, generation Y)
Number of subjects: 3356
Study 34492623 — intervention group
Group type: COMPARATOR
Intervention: Generation Y and Generation X
Number of subjects: 3356
Study 34686204 — intervention group
Group type: EXPERIMENTAL
Intervention: Aclidinium
Number of subjects: 3589
Study 33397449 — intervention group
Group type: EXPERIMENTAL
Intervention: Conestat alfa (8400 U followed by 4200 U every 8 hours for 72 hours) in addition to standard of care (SOC)
Number of subjects: 120
Study 33397449 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC) only
Number of subjects: 120
Study 33397449 — intervention group
Group type: EXPERIMENTAL
Intervention: Conestat alfa (8400 U followed by 4200 U every 8 hours for 72 hours) in addition to SOC
Number of subjects: 120
Study 32054284 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention of obesity (IMOAP) with trained nurse and small periodic work groups (G2)
Number of subjects: 168
Study 32054284 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention of obesity (IMOAP) adding the use of a digital platform (iwopi) (G3)
Number of subjects: 168
Study 32054284 — intervention group
Group type: COMPARATOR
Intervention: Control group (G1)
Number of subjects: 168
Study 32054284 — intervention group
Group type: COMPARATOR
Intervention: Control group (G1) vs Motivational intervention (G2)
Number of subjects: 168
Study 32054284 — intervention group
Group type: COMPARATOR
Intervention: Control group (G1) vs Motivational intervention with digital platform (G3)
Number of subjects: 168
Study 32054284 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention (G2) vs Motivational intervention with digital platform (G3)
Number of subjects: 168
Study 33127746 — intervention group
Group type: EXPERIMENTAL
Intervention: Muc5ac knockout (KCM)
Number of subjects: 2
Study 33127746 — intervention group
Group type: EXPERIMENTAL
Intervention: Silencing of MUC5AC in human pancreatic cancer cells
Number of subjects: 2